Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Revenue

Werewolf Therapeutics had revenue of $742.00K in the quarter ending March 31, 2024, a decrease of -83.38%. This brings the company's revenue in the last twelve months to $16.22M, down -22.26% year-over-year. In the year 2023, Werewolf Therapeutics had annual revenue of $19.94M with 21.60% growth.

• Revenue (ttm): $16.22M
• Revenue Growth: -22.26%
• P/S Ratio: 7.29
• Revenue / Employee: $345,128
• Employees: 47
• Market Cap: 118.63M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	19.94M	3.54M	21.60%
Dec 31, 2022	16.40M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.